Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06207734
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-01-03
Brief Title:
Discontinuation of CDK46 Inhibitors in Patients With Metastatic HR Positive HER2 Negative Breast Cancer
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-10
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-03
First Submit QC Date:
January 12 2024
Study First Post Date:
2024-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-11
Last Update Post Date:
2024-04-12
Last Update Post Date Type:
ACTUAL